Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseases

Autor: Kalpana S. Ramegowda, Ravikumar B. Lakkappa, Giridhar Kamalapurkar, Athira Girijamma, Sumi Surendran, Divya H. Nair, Chandrasekharan C Kartha, Jissa Vinoda Thulaseedharan, Radhakrishnan Nair
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Male
Pathology
lcsh:Medicine
Cardiovascular
Exon
Molecular cell biology
Gene Frequency
Nucleic Acids
Genotype
Gene expression
Genome Sequencing
Promoter Regions
Genetic

lcsh:Science
Peripheral Vascular Diseases
Multidisciplinary
Forkhead Transcription Factors
Genomics
Middle Aged
Functional Genomics
medicine.anatomical_structure
Medicine
Female
Disease Susceptibility
medicine.symptom
FOXC2
Research Article
Adult
medicine.medical_specialty
Adolescent
Clinical Research Design
DNA transcription
Biology
Veins
Molecular Genetics
Young Adult
Vascular Biology
Varicose veins
medicine
Genetics
Humans
Gene Regulation
Vascular Diseases
Vein
HEY2
Gene
Genetic Association Studies
Polymorphism
Genetic

lcsh:R
Genetic Variation
Human Genetics
DNA
Molecular biology
Case-Control Studies
Genetics of Disease
Chronic Disease
biology.protein
lcsh:Q
Gene Function
Zdroj: PLoS ONE, Vol 9, Iss 3, p e90682 (2014)
PLoS ONE
ISSN: 1932-6203
Popis: Chronic venous disease (CVD) is one of the most prevalent yet underrated disorders worldwide. High heritability estimates of CVD indicate prominent genetic components in its etiology and pathology. Mutations in human forkhead box C2 (FoxC2) gene are strongly associated with valve failure in saphenous and deep veins of lower extremities. We explored the association of genetic variants of FoxC2 as well as FoxC2 mRNA and protein expression levels with CVD of lower limbs. We systematically sequenced the single coding exon, 5′ and 3′ flanking regions of FoxC2 gene in 754 study subjects which includes 382 patients with CVD and 372 healthy subjects. Four novel and three reported polymorphisms were identified in our cohort. Three variants in 5′ flanking region and one in 3′ flanking region of FoxC2 gene were significantly associated with CVD risk. FoxC2 mRNA in vein tissues from 22 patients was 4±1.42 fold increased compared to saphenous veins from 20 normal subjects (pT (rs34221221: C>T) variant which is located in the FoxC2 putative promoter region was further analyzed. Functional analysis of c.-512C>T revealed increased mRNA and protein expression in patients with homozygous TT genotype compared to heterozygous CT and wild CC genotypes. Luciferase assay indicated higher transcriptional activity of mutant compared to wild genotype of this variant. These findings suggested that c.-512C>T variant of FoxC2 was strongly associated with susceptibility to CVD and also that this variant resulted in FoxC2 overexpression. To obtain a mechanistic insight into the role of upregulated FoxC2 in varicosities, we overexpressed FoxC2 in venous endothelial cells and observed elevated expression of arterial markers Dll4 and Hey2 and downregulation of venous marker COUP-TFII. Our study indicates altered FoxC2-Notch signaling in saphenous vein wall remodeling in patients with varicose veins.
Databáze: OpenAIRE